Stockscreener 앱 받기
6.56
2.38%
-0.16
시간 외 거래:
6.73
0.17
+2.59%
전일 마감가:
$6.72
열려 있는:
$6.725
하루 거래량:
311.06K
Relative Volume:
1.16
시가총액:
$48.85M
수익:
-
순이익/손실:
$-22.06M
주가수익비율:
-1.2406
EPS:
-5.2876
순현금흐름:
$-17.93M
1주 성능:
+1.08%
1개월 성능:
+1.08%
6개월 성능:
+68.21%
1년 성능:
+74.47%
1일 변동 폭
$6.51
$7.00
1주일 범위
$5.95
$7.00
52주 변동 폭
$3.20
$7.92
Cingulate Inc Stock (CING) Company Profile
명칭
Cingulate Inc
전화
(913) 942-2300
주소
1901 W. 47TH PLACE, KANSAS CITY
Compare CING vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CING
Cingulate Inc
|
6.56 | 50.04M | 0 | -22.06M | -17.93M | -5.2876 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cingulate Inc Stock (CING) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 개시 | ROTH MKM | Buy |
| 2023-12-22 | 다운그레이드 | Laidlaw | Buy → Hold |
Cingulate Inc 주식(CING)의 최신 뉴스
Cingulate (NASDAQ: CING) vote on 19% share issuance and warrants - Stock Titan
Pullback Watch: Is Cingulate Inc Equity Warrant a turnaround storyJuly 2025 Catalysts & Long-Term Growth Plans - baoquankhu1.vn
Risk Hedge: Can Cingulate Inc Equity Warrant maintain its current growth ratePrice Action & Daily Volume Surge Signals - baoquankhu1.vn
CING Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Highlights: Can Cingulate Inc disrupt its industryDividend Hike & Daily Growth Stock Investment Tips - baoquankhu1.vn
CINGW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Buybacks Report: Does COLAR meet Warren Buffetts criteria2025 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
Can Cingulate Inc. Equity Warrant maintain its current growth rate - mfd.ru
What drives Cingulate Inc.’s stock priceJuly 2025 Trade Ideas & Consistent Growth Equity Picks - mfd.ru
Investment deal brings well-known area entrepreneur to Cingulate board - The Business Journals
Activity Recap: What are analysts price targets for Cingulate Inc Equity WarrantQuarterly Growth Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug EndMonth: What are analysts price targets for Cingulate Inc Equity WarrantJuly 2025 Update & Accurate Trade Setup Notifications - baoquankhu1.vn
Volatility Watch: What are analysts price targets for Cingulate Inc Equity WarrantJuly 2025 Rallies & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Cingulate Secures $12 Million PIPE to Advance CTx-1301 - The Globe and Mail
Cingulate Inc. announced that it has received $11.796254 million in funding - marketscreener.com
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Bitget
Cingulate appoints Jeff Hargroves to Board and key committees - TradingView
Earnings Beat: What are analysts’ price targets for Cingulate Inc. Equity WarrantPortfolio Performance Report & Free Technical Confirmation Trade Alerts - mfd.ru
What are Cingulate Inc.’s recent SEC filings showingWeekly Trade Summary & Daily Momentum Trading Reports - mfd.ru
Is Cingulate Inc. Equity Warrant stock supported by innovation pipelineMarket Movers & Risk Managed Investment Signals - mfd.ru
Peter Werth Purchases 19,455 Shares of Cingulate (NASDAQ:CING) Stock - MarketBeat
Shane Schaffer Buys 6,809 Shares of Cingulate (NASDAQ:CING) Stock - MarketBeat
Cingulate (NASDAQ:CING) CFO Jennifer Callahan Purchases 4,864 Shares - MarketBeat
Growth Value: Is Cingulate Inc likely to announce a buybackWeekly Market Outlook & AI Powered Market Entry Ideas - baoquankhu1.vn
Weekly Recap: Is CDROW stock a good dividend stockWeekly Trading Summary & Safe Capital Growth Plans - baoquankhu1.vn
Cingulate Advances Capital Raise with Private Placement Financing - The Globe and Mail
ADHD Drug Maker Cingulate Draws Investor Attention; Stock Up Over 60% In Seven Months - RTTNews
How Cingulate Inc. stock reacts to inflationary pressuresWeekly Risk Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Ideas Watch: Is Cingulate Inc in a long term uptrendQuarterly Investment Review & Weekly Momentum Picks - baoquankhu1.vn
Sentiment Watch: Should I average down on Cineverse Corp stockTrade Exit Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Cingulate Announces Private Placement and New Preferred Stock - The Globe and Mail
Cingulate Signs Multiple Material Agreements - TradingView
Cingulate Inc. announced that it expects to receive $12.011001 million in funding - marketscreener.com
What’s Cingulate Inc.’s historical returnTrading Volume Surges & The Smart Money Is Buying These Picks - bollywoodhelpline.com
Aug Patterns: What is the target price for Cingulate Inc Equity Warrant stockJuly 2025 Technicals & Community Verified Watchlist Alerts - baoquankhu1.vn
Is Cingulate Inc. stock attractive after correctionJuly 2025 Action & Accurate Buy Signal Alerts - bollywoodhelpline.com
Market Pulse: What is the target price for Cingulate Inc Equity Warrant stockExit Point & Short-Term Trading Alerts - baoquankhu1.vn
Cingulate (NASDAQ:CING) Trading 3.1% Higher – Should You Buy? - Defense World
Cingulate Expands At-The-Market Equity Offering Capacity - The Globe and Mail
Cingulate increases at-the-market offering limit to $31.9 million By Investing.com - Investing.com Canada
Cingulate increases at-the-market offering limit to $31.9 million - Investing.com
Cingulate Inc. Increases Offering Price Under Sales Agreement - TradingView
Quarterly Recap: Is Cingulate Inc likely to announce a buybackJuly 2025 Earnings & Precise Swing Trade Alerts - baoquankhu1.vn
Analysis Recap: Why Cingulate Inc stock appeals to analystsForecast Cut & Real-Time Sentiment Analysis - Bộ Nội Vụ
Market Outlook: Will Cingulate Inc Equity Warrant stock remain a Wall Street favoriteJuly 2025 Reactions & High Win Rate Trade Alerts - Bộ Nội Vụ
Cingulate Inc Files For Mixed Shelf Offering Of Up To $200 Million- SEC Filing - TradingView — Track All Markets
Cingulate Retail Buzz Rises After FDA Greenlights Summer NDA Filing For ADHD Drug - MSN
Cingulate price target lowered to $16 from $17 at Roth Capital - MSN
Will Cingulate Inc. stock maintain dividend yieldColor and Style Update & trail grip notes for mixed terrain - ulpravda.ru
Why Cingulate Inc. stock remains a top recommendation2025 Breakouts & Breakdowns & Stepwise Swing Trade Plans - Улправда
What analyst consensus says on Cingulate Inc. stockTake Profit & Safe Entry Zone Tips - Улправда
Cingulate Inc (CING) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):